
Can We Utilize Existing Cancer-Related Therapies to Help COVID-19 Patients?
Author(s) -
Catlin Nalley
Publication year - 2020
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000661876.33887.58
Subject(s) - medicine , tocilizumab , cytokine storm , cytokine release syndrome , ards , immunotherapy , intensive care medicine , cancer , covid-19 , chimeric antigen receptor , immunology , lung , rheumatoid arthritis , disease , infectious disease (medical specialty)